CN112047919A
|
|
Ticagrelor intermediate and preparation method thereof
|
CN111978333A
|
|
Crystal form A of Bictegravir sodium salt, preparation method and application
|
CN111763176A
|
|
GnRH receptor antagonist key intermediate and preparation method thereof
|
CN111607019A
|
|
Purification method of sugamonic acid
|
CN111610273A
|
|
High performance liquid chromatography analysis method for dihydralazine sulfate related substances
|
CN111413425A
|
|
Ultra-high performance liquid chromatography analysis method for clozapine-related substances
|
CN111297818A
|
|
High-drug-loading-capacity piracetam tablet composition and preparation method thereof
|
CN111423341A
|
|
Piracetam related substance and analytical detection method thereof
|
CN110981859A
|
|
Domperidone related substance and preparation, analysis and detection method thereof
|
CN111018844A
|
|
Preparation method of sofosbuvir key intermediate
|
CN111072467A
|
|
Preparation method of ticagrelor key intermediate
|
CN110294665A
|
|
The recyclable device and recovery method of ethyl alcohol in Doxycycline Hyclate refinement mother liquor
|
CN112010857A
|
|
Crystal form of ribociclib succinate
|
CN110117309A
|
|
Isomer impurities and its synthetic method in a kind of enalapril maleate bulk pharmaceutical chemicals
|
CN110156768A
|
|
A kind of preparation and its application of the key intermediate of razaxaban
|
CN109678737A
|
|
A kind of preparation method of Pregabalin
|
CN109879843A
|
|
A kind of intermediate of Ba Luoshawei and the preparation method and application thereof
|
CN109293631A
|
|
The preparation method of 3- amino-N- (2,6- dioxo -3- piperidyl)-phthalimide compound
|
CN109288836A
|
|
A kind of dihydralazine sulfate,clonidine and hydrochlorothiazine preparation and its preparation method and application
|
CN108997313A
|
|
PARP inhibitor key intermediate and preparation method thereof
|